Champions Oncology (CSBR) Q2 2026 Earnings Report

143 Followers

CSBR Q2 2026 EPS Results

Actual EPS$0.06

Consensus EPS$0.00

Beat/MissBeat by +$0.06

One Year Ago EPS$0.05

Actual Revenue$15.04M

Expected Revenue$14.04M

Beat/MissBeat by +$993.00K

YoY Revenue Growth+11.46%

QuarterQ2 2026

Date12/15/2025

TimeAfter Close

Conference CallMonday, December 15, 2025

CSBR Upcoming Earnings

Champions Oncology's next earnings date is estimated for December 15, 2026, based on past reporting schedules.

CSBR Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 15, 2026	2027 (Q2)	- / -	0.06	―
Sep 10, 2026	2027 (Q1)	- / 0.05	0.02	150.00% (+0.03)
Jul 27, 2026	2026 (Q4)	- / 0.01	-0.07	114.29% (+0.08)
Mar 12, 2026	2026 (Q3)	0.09 / -0.02	0.36	-105.56% (-0.38)
Dec 15, 2025	2026 (Q2)	0.00 / 0.06	0.05	20.00% (<+0.01)
Sep 15, 2025	2026 (Q1)	-0.01 / 0.02	0.11	-81.82% (-0.09)
Jul 23, 2025	2025 (Q4)	-0.20 / -0.07	0.01	-800.00% (-0.08)
Mar 11, 2025	2025 (Q3)	-0.01 / 0.36	-0.16	325.00% (+0.52)
Dec 11, 2024	2025 (Q2)	0.01 / 0.05	-0.15	133.33% (+0.20)
Sep 11, 2024	2025 (Q1)	-0.03 / 0.11	-0.16	168.75% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed